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Abstract 
Objective: To compare the clinical outcomes of microwave endometrial 
ablation (MEATM) and thermal balloon ablation (TBall) for the treatment of 
heavy menstrual bleeding 
 
Design:  A double blind randomised controlled trial  
 
Setting: A UK teaching hospital 
 
Population: 320 women requesting endometrial ablation 
 
Methods: Operative data collection and patient completed postal 
questionnaires were utilised to ascertain women’s satisfaction with outcome, 
acceptability of each procedure, changes in menstrual symptoms and health 
related quality of life,  and additional treatments received.  
 
Main outcome measures: Primary outcomes were satisfaction and menstrual 
scores one year. Secondary outcomes were operative differences, 
acceptability of treatment and changes in health related quality of life. 
 
Results: - Both technologies achieved high levels of satisfaction (-1%, 95% CI 
(-11, 9)). Menstrual scores were also similar (4%, 95% CI (-7, 19)) Microwave 
had a significantly shorter operating time, reduced usage of antiemetics and 
opiate analgesia, increased discharge by six hours and fewer device failures.  
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Conclusions  
Both treatments are acceptable to women, with high levels of satisfaction. 
Microwave is quicker to perform with faster hospital discharge . 
Key words 
Menorrhagia, randomised trial, surgical treatments 
Trial registered online at:  
http://www.controlled-trials.com/ISRCTN28184453 
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Clinical outcomes of Microwave Endometrial Ablation v Thermal Balloon 
Endometrial Ablation – a randomised comparison. 
 
Introduction 
The surgical treatment of heavy menstrual loss has been revolutionised over 
the last fifteen years with the widespread introduction of endometrial ablation. 
First generation hysteroscopic endometrial ablative techniques (transcervical 
resection of the endometrium (TCRE), rollerball and laser) are successful but 
require high levels of skill.1-5 This led to the development of second generation 
techniques which are technically much simpler to perform, but the majority of 
which are not performed under direct hysteroscopic vision.1-5 There is a 
wealth of robust evidence comparing first generation endometrial ablation 
techniques to hysterectomy1-5 whilst second generation techniques have been 
compared with first generation techniques, in order to prove their efficacy.6-15 
Good quality randomised trials comparing clinical outcomes and costs 
between the different varieties of second generation ablative techniques are 
less common.16-18 We aimed to rectify this with a comparison of the two 
second generation techniques most commonly used in the UK, microwave 
endometrial ablation (MEATM) and thermal balloon endometrial ablation 
(TBall). This is in accordance with a recommendation from the National 
institute for Health and Clinical Excellence (NICE).19  
 
Methods 
Participants 
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Women complaining of heavy menstrual loss and requesting endometrial 
ablation were recruited by a research fellow from the gynaecology department 
of Aberdeen Royal Infirmary in the UK during the period January 2003 to 
January 2005. Patients were eligible if they were pre-menopausal, had 
completed their families, and had a uterine size equivalent to a twelve week 
pregnancy or less with no histopathological abnormalities of the endometrium 
and no fibroids obstructing the uterine cavity. Women with lower segment 
caesarean scars were included if their scar thickness was greater than 10mm 
on transvaginal ultrasound. All women gave informed consent to participate in 
the trial. The patients did not routinely undergo hysteroscopy prior to 
recruitment, unless transvaginal ultrasound scan suggested an abnormal 
uterine cavity. 
 
Interventions 
Procedures were undertaken in the post menstrual phase. This was either 
achieved by natural cycle or by a withdrawal bleed induced by Provera 10mg 
twice a day or norethisterone 5mg three times a day for seven days. 
Treatment was scheduled ten days after stopping the tablets. 
 
Treatments were performed in day surgery theatres unless there were specific 
patient medical contraindications, for example BMI outwith the day surgery 
range. Treatments were either performed under general anaesthetic or local 
anaesthetic, with or without conscious sedation dependant on patient 
preference. Patients received a 100mg Diclofenac suppository 1 hour prior to 
treatment (patients in whom this was contraindicated received 1g 
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Paracetamol rectally). Intravenous access was achieved prior to 
commencement of the procedure. Those opting for local anaesthesia received 
a four quadrant intracervical block using four 2.2ml ampoules of Citanest (3% 
Prilocaine with Felypressin 2.2ml). They were offered intravenous sedation 
with Midazolam (2-4mg iv), either from the outset or at their request intra-
operatively. If intra-operative analgesia was required intravenous Fentanyl 
was given (25-50mcgs). A member of theatre staff provided reassurance and 
verbal support throughout the procedure. Patient oxygen saturation and heart 
rate were monitored throughout the procedure.  
The cervix was then dilated to 9mm for the MEATM group and 5mm if 
necessary for the TBall group. A gas hysteroscopy (or saline if the view was 
poor, was then performed in all patients to identify the cavity and exclude 
false passages or perforations, immediately prior to device insertion. Women 
with submucous fibroids of less than 3cm were treated in the same fashion as 
those with normal cavities. Intrauterine polpys were removed under direct 
vision and treated in the same fashion, provided prior histology was within 
normal limits. Microwave ablation was performed in the standard fashion.21 
The TBall procedure was adapted from the standard method9 by adding fluid 
to the balloon if necessary during the treatment cycle in order to maintain 
intracavity pressure at 160 -180mmHg. Total procedure time was taken from 
insertion of intra venous access to the patient leaving theatre. Procedure time 
(ablation) was taken from insertion of probe to removal of probe.  
 
Post operatively, once comfortable, voiding and tolerating diet; patients were 
discharged with an information sheet and contact telephone number.  
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Objectives 
To compare the clinical outcomes of microwave endometrial ablation (MEATM) 
and thermal balloon ablation (TBall) for the treatment of heavy menstrual 
bleeding. 
 
Outcomes 
Primary outcomes were satisfaction and menstrual scores one year. 
Secondary outcomes were operative differences, acceptability of treatment, 
and changes in health related quality of life.. 
Patients completed pre-operative questionnaires to obtain baseline menstrual 
details. These included both PBLAC22 and a menstrual bleeding and pain 
score used in previous endometrial ablation trials from this centre.7,23-25 The 
woman rated the blood loss on a scale from 1 least to 5 greatest for each day 
of her period. These values were then added for a total menstrual blood loss 
score. Menstrual pain was rated in an identical manner, in order to give a total 
pain score for the period. Baseline health-related quality of life parameters 
(Short form 1226 and EQ-5D27) and an assessment of anxiety/ depression 
(Hospital Anxiety and Depression Score28) were also completed. 
 
The questionnaires were repeated post treatment, at two weeks, six months 
and one year following the procedure.  
Acceptability of the procedure and a pain questionnaire were completed on 
the day of surgery and two weeks post operatively. Acceptability of the 
procedure was assessed using a six-point scale and on a 10cm visual 
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analogue scale (0cm = totally acceptable, 10cm = totally unacceptable). Pain 
was assessed using a modified version of the McGill Questionnaire29. 
Satisfaction with the outcome was measured at one year post procedure on a 
six-point scale from  totally satisfied through to totally dissatisfied. 
 
Sample Size 
It was calculated a priori that 290 patients would be required to achieve 80% 
power to detect a 12% difference in those totally or generally satisfied with 
treatment.  This number gives 80% power to detect a 15% difference in 
amenorrhoea rates (2p < 0.05). This is based on the only randomised trial 
evidence that established amenorrhoea rates for MEA™ at one year of 40 % 
and of TBall of around 20%. 20,21 This number of patients would also give 90% 
power to detect a difference in menstrual scores (pictorial blood loss 
assessment chart, PBLAC) of 10, again significant at the 5% level.  To 
account for drop outs 320 women were recruited to the trial. Previous ablation 
studies at this centre have shown up to a 20% loss to follow up by five years. 
 
Randomisation 
Patients were randomised in a ratio of 1:1 to the MEATM and TBall arms of the 
study. Computer generated randomly permuted blocks were used with a 
telephone randomisation service based on a separate site to achieve 
concealment.  
 
Blinding  
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The treatment allocation was not revealed to the participants during the 
course of the study. Outcome assessment was collected by means of patient 
completed questionnaires with the exception of the operative questionnaire 
data. The data was entered and analysed independently by researchers 
unaware of the treatment allocation. 
 
Statistical analysis 
All statistical analyses were carried out using SPSS v14 unless otherwise 
stated. Intention to treat analysis was utilised; that is each participant 
remained in their initially allocated group irrespective of the treatment 
received. A 95% confidence interval for the difference in proportions was 
calculated in Excel using Newcombe’s method.30 Health related quality of life 
measures (EQ-5D and SF-12 scores) were compared using a linear 
regression model to estimate the mean difference between groups, after 
adjusting for baseline values. Where appropriate, to account for skewness 
and an excess number of zeroes in an outcome, a zero inflated negative 
binomial regression model31 was used to estimate the incidence rate ratio 
(IRR) and 95% confidence intervals between groups,  using STATA 9SE.  
Adjustment was made in the model for baseline values.  The McGill pain 
score was generated using the rank weight method with a comparison 
between groups made using a Mann-Whitney test. The acceptability visual 
analogue scale was also compared using a Mann-Whitney test.  Procedure 
times were compared using an independent t-test. A zero value was imputed 
for twelve months bleeding/pain scores PBLAC where the participant had 
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stated they no longer having periods. The CONSORT scheme32 of reporting 
was adhered to. 
 
 
Results  
Study recruitment commenced in January 2004 and treatments were 
completed by January 2007. Three hundred and twenty women were 
randomised with 157 in each arm receiving treatment (Figure1). There were 
six post randomisation exclusions (four withdrew consent and two were found 
to be unsuitable for treatment following randomisation.) These women are not 
included in the analysis as they withdrew prior to treatment. 
Three patients withdrew following treatment one in the MEATM arm and two in 
the TBall arm. 
 
AS, a specialist registrar (trainee) undertook the majority of the procedures 
under indirect supervision,  (93%) with a consultant, K.C., undertaking the 
remainder.  
 
Baseline characteristics for both groups were very similar (Table 1). 
 
The number of participants who received their allocated treatments is reported 
in table 2. Three women in the MEATM arm were found to have unsuitable 
cavities of greater than 12cm on the day of surgery, despite pre assessment 
in a gynaecology clinic. These women underwent TCRE.  Four women in the 
TBall arm were also found to have unsuitable uterine cavities of greater than 
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12 cm; two underwent TCRE, one had a rollerball and underwent 
hysterectomy.  The single device failure in the MEA™ arm was due to 
moisture in the data cable, this patient underwent TCRE. The eleven device 
failures in the TBall arm were all due to failure in maintaining a stable 
intrauterine pressure despite an intact uterine cavity. Four of these women 
underwent TCRE, two had rollerball ablation and five women had MEA™. A 
failure in the sterile services department affected one operating list, leading to 
one woman in the MEATM arm having rollerball ablation and one woman 
having TBall. 19% of women in the MEATM arm and 14% of the TBall arm had 
either polyps or fibroids in the uterine cavity. Women were free to choose their 
method of anaesthetic either local or general. Similar numbers of around 60% 
in each group requested the procedure under general anaesthetic. In those 
who chose local anaesthetic there were no failures or conversion to general 
anaesthetic in either group. 
 
Operative differences show a significant difference between MEATM and TBall 
in total procedure time (from insertion of intravenous access to leaving 
theatre, (mean difference -5.9 min, 95% CI -8.5 min, -3.3 min) and in 
procedure time (insertion of probe to removal of probe (mean difference -6.6 
min; 95% CI -7.4 min, -5.8 min) (Table 2). The median procedure related 
discomfort of both procedures was 3 on a scale of 1 none to 6 excruciating). 
 
A further difference was demonstrated in the requirement for opiate analgesia 
and antiemetic medication between the two groups (Table 3), with the MEATM 
group requiring significantly less (difference -22%, 95% CI (-32%, -11%)). 
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There were no serious complications in either group. By six hours, 
significantly more of the MEATM group 124 (79%) were suitable for discharge 
home compared to 106 (68%) of the TBall group (difference 11%, 95% CI 1%, 
20%).  
 
High levels of acceptability with the procedure were found in both groups at 
two weeks with 118 (81%) of the MEA™ group and 122 (87%) of the TBall 
group describing their treatment as totally or generally acceptable (difference 
in proportion -6%; 95% CI -15%, 2%).   There was a high level of satisfaction 
at twelve months with 109 (76%) of the MEA™ group and 103 (77%) of the 
TBall group described themselves as totally or generally satisfied with their 
procedure (difference in proportion -1%, 95% CI -11%, 9 %). The majority of 
women 91% for MEATM and 92% for TBall would recommend the treatment to 
a friend at twelve months.  
 
 
Menstrual outcomes between the two groups were comparable at twelve 
months (Table 4) both for PBLAC, pain and bleeding scores. 41% of the 
MEATM group and 38% of the TBall group were amenorrhoeic. There were six 
hysterectomies in the MEATM group and six in the TBall group (0.03%, 95% CI 
(-5%, 5%) ). Quality of life scores (both physical and mental components) 
were not significantly different between the groups (Figure 2). 
 
Discussion 
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This study demonstrates that MEATM and TBall are both acceptable 
treatments which achieve high satisfaction rates for patients wishing treatment 
for their heavy menses. Patient quality of life shows an overall sustained 
improvement following both treatments.  
 
Thermal balloon ablation achieved a high rate of amenorrhoea in this study 
when compared to previous reported randomised controlled trials.9,17,18 This 
may be due to the active circulation of fluid within the Thermachoice III 
catheters.33 We feel that the addition of fluid into the balloon during the 
treatment cycle to maintain the treatment pressure above 160mmhg may also 
be important. This is not recommended practice by the manufacturer, at 
present. The amenorrhoea rates for microwave ablation are at the lower end 
of reports from other randomised trials from this and other centres7,8 This may 
represent the relative inexperience of the surgeon with this technique. The 
trainee had five years experience of the TBall technique, but had only recently 
been trained in the microwave procedure, having done five procedures 
independently prior to starting the trial.  
 
 
It was felt important that the patients received treatment on the day of 
attending for surgery and hence an alternative method was used if there was 
a failure of the allocated treatment. 
 
Both techniques are amenable to use under local anaesthesia with or without 
sedation. No patient required conversion to a general anaesthetic, this 
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concurs with previous trials evaluating MEA™ under local anaesthesia and in 
the office setting.21-23 
 
Differences in time to discharge were not affected by timing of the theatre 
lists. The majority of patients were operated on in the afternoon research 
operating list with only those women with medical reasons being performed 
on a morning in-patient list. There was no difference in timing of procedure on 
the lists between the two groups. Patients were given the next space on the 
research list following randomisation, minimising potential bias in this respect.  
 
The operative time differences between the two groups were predictable. 
TBall requires several minutes in order to achieve a stable intrauterine 
pressure and pre heating phase prior to the eight minute treatment cycle. The 
treatment cycle for MEATM can begin immediately after insertion of the probe.  
 
Procedure failures are an important consideration when choosing a second 
generation method. There was only one MEA™ device failure with eleven 
device failures in the TBall arm. These tended to be in women with large 
cavities and wide intercornual distances where it was not possible to achieve 
adequate intrauterine pressures in order to start the treatment cycle.  The 
device failure in the MEA™ arm was due to moisture within the data cable. If 
disposable MEA™ probes (Femwave™) had been used this would not have 
occurred. 
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In this study no serious complications occurred with either technique. We feel 
that routine hysteroscopy prior to the start of the ablation minimises the risks 
of complications by excluding perforation and false passage, and confirmation 
of endometrial cavity by visualising cornuae.. There are documented cases of 
perforation and visceral damage for both techniques on the MAUDE 
database. 
 
The generalisability of the results to a wider population is enhanced by the 
avoidance of entry criteria based on menstrual blood loss scores or a regular, 
normal sized uterine cavity, making this truly pragmatic. The results of the 
study would be genuinely reproducible if the practice of maintaining balloon 
were to become accepted practice. If not it is possible that lower amenorrhoea 
rates would occur following balloon ablation. 
 
This is the first randomised controlled trial between these two second-
generation ablation techniques. Whilst it appears that both treatments are as 
efficacious as each other, with the exception of a larger uterine cavit;, in a 
climate of financial restraint MEA™ may have an economic advantage over 
TBall. Long-term follow up will be performed to compare satisfaction, 
menstrual outcomes and rates of further surgery between the two groups. The 
majority of repeat procedures and hysterectomies are known to take place 
within 24 months of MEA™, and rarely after three years.7   
 
In conclusion both MEA™ and TBall achieve high levels of patient satisfaction 
and are acceptable to patients. Both techniques have similar effectiveness at 
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least up to a twelve month follow-up. MEA™ is quicker, has less failures, isnot 
limited by the larger cavity and leads to quicker discharge.This  provides 
valuable information to healthcare purchasers looking to purchase a second 
generation ablation device. 
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